Corbus Pharmaceuticals Holdings (CRBP) Treasury Shares (2013 - 2023)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Treasury Shares came in at $17911.0 in Q4 2023, down 26.17% quarter-over-quarter from $24259.0 in Q3 2023.
Corbus Pharmaceuticals Holdings (CRBP) Treasury Shares (2013 - 2023) Analysis & Trends
Corbus Pharmaceuticals Holdings' Treasury Shares history runs 2 years deep, the most recent figure standing at $17911.0 for Q4 2023.
- On a quarterly basis, Treasury Shares changed N/A year-over-year to $17911.0 in Q4 2023; TTM through Dec 2023 was $17911.0, a N/A change from a year earlier, with the FY2023 full-year figure at $17911.0, changed N/A from the prior year.
- Treasury Shares fell to $17911.0 in Q4 2023 per CRBP's latest filing, from $24259.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $24259.0 in Q3 2023 and bottomed at $17911.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 17,911.00 |
| Dec 31, 2023 | 17,911.00 |
| Sep 30, 2023 | 24,259.00 |
| Sep 30, 2023 | 24,259.00 |
| Jun 30, 2023 | 21,342.00 |
| Jun 30, 2023 | 21,342.00 |
| Mar 31, 2023 | 23,990.00 |
| Mar 31, 2023 | 23,990.00 |
| Dec 31, 2013 | 1.84 Mn |
| Dec 31, 2013 | 1.84 Mn |